Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Echinacea and Increased Interleukin 8 Levels

Doses used in studies
  • g/day: 10.2–5.1 (median 7.65, IQR 10.25.1) 1 study
Time to effect
Median: 5 days · IQR 5 days5 days · Range 5 days5 days — Reported in 1 of 1 study
1 of 1 paper
  • Echinacea for treating the common cold: a randomized trial.

    • 2010-12-21
    • RCT · n = 719
    • Annals of internal medicine 153(12)
      • Bruce Barrett
      • Roger Brown
      • Dave Rakel
      • Marlon Mundt
      • Kerry Bone
      • Shari Barlow
      • Tola Ewers
    • High evidence
    • Large Human Trial
    • Rigorous Journal
    • Clinical

    Median change in interleukin-8 levels and neutrophil counts were also not statistically significant (30 ng/L and 1 cell/high-power field [hpf] in the no-pill group, 39 ng/L and 1 cell/hpf in the blinded placebo group, 58 ng/L and 2 cells/hpf in the blinded echinacea group, and 70 ng/L and 1 cell/hpf in the open-label echinacea group).

    Effect
    Neutral
    Effect size
    Small
    Significant
    No
    Dose
    equivalent of 10.2 g of dried echinacea root during the first 24 hours and 5.1 g during each of the next 4 days
Back to top